Jan 21, 2010 by Brian Orelli, PhDHere's That Critical Merck Info You MissedAnnouncing clinical trial failures in a FAQ? Really?
Jan 21, 2010 by Brian Orelli, PhDThe Noble Gesture That Wasn'tThere may be a motive behind Glaxo helping to develop malaria treatments.
Jan 20, 2010 by Brian Orelli, PhDHealth-Care Reform: It's Not Over YetMassachusetts has spoken. What's up next?
Jan 19, 2010 by Brian Orelli, PhDPfizer Gets Serious About GenericsSerious, as in a potential $4-billion-purchase serious.
Jan 19, 2010 by Brian Orelli, PhDMonsanto's Legal Wins Are Just the BeginningThe lawyers may affect the stock price for a while.
Jan 15, 2010 by Brian Orelli, PhDOops, Sorry About That, PfizerThe FDA says there's no problem with Spiriva after all.
Jan 15, 2010 by Brian Orelli, PhDThe Odor Lingers at Johnson & JohnsonThe company has to recall products because of a smelly problem.
Jan 15, 2010 by Brian Orelli, PhDMonsanto Rounds Up Documents for the DOJThe government investigates the agriculture giant.
Jan 14, 2010 by Brian Orelli, PhDJPMorgan Challenge: Do You "Heart" This Company?A look at Edwards Lifesciences and its heart valves.
Jan 13, 2010 by Brian Orelli, PhDJPMorgan Challenge: On the Cusp of GreatnessMedivation has a partner and is ready for phase 3 data to roll in.
Jan 12, 2010 by Brian Orelli, PhDJ.P. Morgan Challenge: Making Money Off Molars EditionAn overview of dental supply company, Dentsply.
Jan 12, 2010 by Brian Orelli, PhDSwine Flu: The Side Dish That Couldn't LastMore governments canceling vaccine-purchasing contracts.
Jan 12, 2010 by Brian Orelli, PhDTysabri: It's a Blockbuster! Yawn. So What?Is it really a big deal that Tysabri finally achieved blockbuster status?
Jan 8, 2010 by Brian Orelli, PhDPfizer's Having a Garage SaleIf it can get something for its old junk, I guess, why not?
Jan 8, 2010 by Brian Orelli, PhDHeartburn Relieved ... for NowAstraZeneca settles its patent dispute with Teva.
Jan 7, 2010 by Brian Orelli, PhDWarning: Potential Anemic Growth AheadAnemia-drug makers get more scrutiny from the FDA.
Jan 7, 2010 by Brian Orelli, PhDPfizer Strides Farther Into GenericsPfizer's new look might be just what the doctor ordered.
